SIO 17th International Conference Rescheduled to September 24-26, 2021 

Read letter from SIO President, Ting Bao, MD, DABMA, MS.


SIO Abstract Submissions Portal Will Re-Open in Early 2021

Due to the 17th International Conference being postponed until September 24-26, 2021, we have closed the abstract submisssions portal. Please watch for notifications of its re-opening in early 2021. All abstracts that have been submitted to date will be saved and submitted to the review committee. 



Clinical Practice Guidelines

SIO is pleased to provide its updated clinical practice guidelines for breast cancer. In June 2018, ASCO announced endorsement of the guidelines. The guidelines were published in 2017. Researchers analyzed which integrative treatments are most effective and safe for patients with breast cancer. The guidelines are a resource for clinicians and patients to inform evidence-based decisions on the use of integrative therapies during breast cancer treatment. Researchers at US and Canadian institutions evaluated the efficacy and safety of more than 80 therapies.

The Journal of the National Cancer Institute Monograph has  published a special issue co-sponsored by SIO, "Advancing the Global Impact of Integrative Oncology"; including a comprehensive definition for integrative oncology. The articles in the special Monograph were all peer-reviewed.




SIO Wellness Wednesday Programs Are Coming Soon!

SIO's 20-minute recorded wellness programs, produced by SIO's Yoga SIG, will feature a new program each Wednesday at 12:00 pm ET, beginning June 10 and running through Labor Day. Our first program, "Intro to Mindfulness" will be available next Wednesday. More details will follow, so please look for information here and on social media.

"The Use of Traditional Chinese Herbal Medicine in COVID-19 - Where's the Evidence?"

Webinar presentation by Weidong Lu, MB, MPH, PhD, Dana-Farber Cancer Institute - recording now available on YouTube.

TCM and Integrative Oncology Practice in China During COVID-19 Outbreak

by Yufei Yang, MD 

Given the rapidly progressing global COVID-19 crisis, SIO leadership has decided to launch a COVID-19 column to specifically address our members’ needs. Our first interview is with Yufei Yang, MD, who is the director of integrative oncology at Beijing Xiyuan Hospital. We would like to learn from our Chinese colleagues’ recent advances in combating COVID-19. This is in keeping with SIO’s practice of facilitating opportunities to share our members’ experiences and perspectives. The full article - TCM and Integrative Oncology Practice in China During COVID-19 Outbreak represents Dr. Yang and her team’s views only.


Call for Applications: SIO 2020 Africa Travel Scholarship - Postponed Until 2021

Please watch for details in early 2021.


Watch Video on Abstract Writing Best Practices 

Please be sure to watch this video in preparation for submitting abstracts in early 2021.


SIO 2019 Conference Presentations Available on VuMedi

As a resource to SIO conference attendees, presentations from SIO's 16th International Conference in NYC are now accessible through, a video hosting platform that posts content from a broad range of healthcare organizations and medical professionals.

May Research Findings

In this interesting vignette based study, 942 physicians and nurses were asked what advice they would give in different patient scenarios where the dynamic variables included patient age and whether the patient finished definitive treatment or not yet. A total of 2303 recommendations were coded and 71.8% regarded an increase in physical activity, 64.3% nutrition, 36.7% psychological support, 29.2% medicine support, 17.2% conscious living, 12.3% naturopathy. Psychological support was increasingly recommended if the patient was still undergoing treatment. Exercise was increasingly recommended if the patient had completed treatment. Considering the growing research evidence that exercise is beneficial even during treatment, this study captures some of the biases and fears clinicians have regarding evidence-informed treatment options. Read the study here.

In an important follow up study, Boyle et al showed that amongst 22 women with breast cancer who completed a 6 week mindfulness meditation intervention, amongst those who had significant increases in eudaimonic well-being (happiness generated by finding a meaning/purpose, as opposed to hedonic well-being which is happiness generated by pursuing objects/activities that produce pleasure, and avoidance of pain) versus those who did not, they had significantly decreased global CTRA (conserved transcriptional response to adversity) scores. But for all 22 women who participated in the study, average global CTRA score did not significantly decrease. Previously the authors and other groups showed that chronic adversity and distress can lead to higher global CTRA scores, i.e. increased expression of pro-inflammatory genes and decreased expression of antiviral and antibody-related genes. This study established that longitudinal changes of eudaimonic well-being within one patient/individual can actually lead to detectable and significant differences in transcriptional response at the cellular level. Of note, the improvements in the global CTRA score amongst patients with improved eudaimonic well-being were primarily driven by an improvement in the antiviral/antibody CTRA component of the score, not the pro-inflammatory CTRA component which had no significant changes. These insights might help scientific investigators better identify the "active ingredients" in an effective mind-body intervention. Read the study here. 


  • @Integrativeonc Wellness Wednesdays - #SIO special summer series - starts June 10 at noon, ET. First program is "I…

  • Add to your calendars: "Dying and Living in A Plague Year, Friday June 19, 9am-10:30am PDT. #Integrativemedicine…

  • RT @sloan_kettering: Which complementary therapies work best for people with #breastcancer? Our Q&A with Dr. Gary Deng…